Related Experiment Videos
Cycloheximide and passive avoidance memory in mice: time-response, dose-response and short-term memory
Pharmacology, Biochemistry, and Behavior
|April 1, 1976
Summary
Cycloheximide (CXM) significantly impairs memory in mice, causing dose-dependent amnesia that persists for up to 14 days. However, the passive avoidance task may be unreliable for assessing short-term memory due to injection stress.
Area of Science:
- Neuroscience
- Pharmacology
- Animal Behavior
Background:
- Memory loss is a critical area of study in neuroscience.
- Cycloheximide (CXM) is known to affect protein synthesis, a process crucial for memory consolidation.
- Understanding drug effects on memory requires reliable behavioral assays.
Purpose of the Study:
- To investigate the amnesic effects of cycloheximide (CXM) on memory retention in mice.
- To determine the dose-dependency and time-course of CXM-induced amnesia.
- To evaluate the suitability of the passive avoidance task for assessing drug-induced memory impairment.
Main Methods:
- Mice were trained using a passive avoidance task.
- Cycloheximide (CXM) was administered subcutaneously at various doses (30-150 mg/kg) before training.
- Memory retention was tested at 1, 7, and 14 days post-training.
- Control groups received saline or lignocaine injections to assess stress effects.
Main Results:
- Cycloheximide (CXM) administration (120 mg/kg) 30 min before training induced significant amnesia, evident 24 hr after learning.
- The amnesic effect was dose-dependent, with higher doses causing greater memory loss.
- Memory loss remained consistent across 1, 7, and 14-day testing intervals.
- Saline controls exhibited unexpectedly low avoidance at 6 hr, suggesting potential stressor effects from injection procedures.
Conclusions:
- Cycloheximide (CXM) effectively impairs long-term memory consolidation in mice.
- The passive avoidance task's sensitivity to injection stress may confound the assessment of short-term memory effects of drugs.
- Further validation of behavioral paradigms is needed for accurate drug efficacy studies on memory.